Key result
Atf3 deletion promotes differentiation of mouse embryonic stem cells into beating cardiomyocytes.
Deletion of Atf3 in mouse embryonic stem cells promotes differentiation into cardiac progenitors and cardiomyocytes, highlighting a potential target for cardiac regeneration therapies.
Atf3 knockout enhances mESC cardiomyocyte differentiation; leaves open whether targeting improves stem-cell therapy post-MI.
Myocardial infarction is associated with massive cardiomyocyte loss, and embryonic stem cells (ESCs), owing to their cardiomyocyte differentiation ability, have emerged as a promising therapy. One potential factor involved in regulating ESC-to-cardiomyocyte differentiation is activating transcription factor 3 (Atf3), and this study clarifies its involvement. Atf3 was knocked out (ko) in mouse ESCs (mESCs) with CRISPR/Cas9. Both wild-type (WT) and Atf3-KO mESCs formed embryoid bodies (EBs) over 6 days, followed by adherent culture to induce cardiomyocyte differentiation from days 7-12; there, Atf3-KO had more beating EBs, at higher frequencies, from Day 8 of differentiation than WT. They also had increased expression of mesodermal markers on Days 3-6 (ex. T), cardiac progenitor markers on Days 6-9 (ex. Pdgfra), and cardiomyocyte differentiation marker on Days 9-12 (ex. cardiac troponin T), as measured by RT-qPCR and flow cytometry. Furthermore, cardiomyocyte differentiation-associated differentially-expressed genes were significantly upregulated in Atf3-KO EBs, compared to WT, under Gene Set Enrichment Analysis of RNA sequencing. All these effects in Atf3-KO mESCs were reversed upon "rescue", where Atf3 expression was restored in these cells. Therefore, Atf3-KO in mESCs promotes differentiation into mesodermal lineages, which further differentiate into cardiac progenitors, serving as a target for cell-based cardiac regeneration therapies.
No takes yet. Share an insight, caveat, or question.
Su et al. (2026) studied this question. Atf3 knockout via CRISPR/Cas9 vs. Wild-type (WT) mouse embryonic stem cells was evaluated on Cardiomyocyte differentiation (beating embryoid bodies and cardiac marker expression). Deletion of activating transcription factor 3 (Atf3) in mouse embryonic stem cells promoted differentiation into mesodermal lineages and subsequently into beating cardiomyocytes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: